Progression of abnormal MIB-1 staining patterns of reserve cells in cervical smears from women ultimately developing high grade squamous intraepithelial lesions

Acta Cytol. 2006 Nov-Dec;50(6):637-42. doi: 10.1159/000326052.

Abstract

Objective: To assess, in a longitudinal study in women diagnosed with high grade squamous epithelial lesion (HSIL), the progression over time of proliferative activity in reserve cells using population screening cervical cytology specimens.

Study design: Twenty consecutive, unselected patients with HSIL lesions were part of the national cervical screening program. From the archives, for each patient, the last prior normal population screening smear was included in the study. Concurrent sets of cervical smears from 80 age-matched women without pathology formed the controls. The original slides were stained using MIB-1 monoclonal antibody. The fraction of MIB-1-positive reserve cells was assessed using systematic random sampling and running progressive means assessment to ensure a sufficient sample size.

Results: The proliferation fraction in reserve cells of HSIL patients was significantly raised (mean, 65.0%; range, 53.5-94.1%; p < 0.01) as compared with that in concurrent controls (mean, 12.8%; range, 1.9-45.4%). Prior smears from HSIL patients, although without morphologic abnormalities, had abnormally high proliferation fractions (mean, 59.1%; range, 1.0-94.7%), significantly raised over those from concurrent controls (mean, 9.4%; range

Conclusion: In population-based cervical smear screening, HSIL patients already have abnormally raised proliferation fractions of reserve cells, even without morphologic changes in squamous cells, 1-5 (mean, 3.6) years prior to diagnosis.

MeSH terms

  • Biomarkers, Tumor / analysis
  • Cell Count
  • Cell Proliferation
  • Cell Transformation, Neoplastic / chemistry*
  • Cell Transformation, Neoplastic / pathology
  • Cervix Uteri / chemistry
  • Cervix Uteri / pathology
  • Disease Progression
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Ki-67 Antigen / analysis*
  • Observer Variation
  • Prognosis
  • Reproducibility of Results
  • Uterine Cervical Dysplasia / chemistry*
  • Uterine Cervical Dysplasia / pathology
  • Uterine Cervical Neoplasms / chemistry*
  • Uterine Cervical Neoplasms / pathology
  • Vaginal Smears*

Substances

  • Biomarkers, Tumor
  • Ki-67 Antigen